Investor Stock List
Ranked #2,710 of 8,699 institutional investors

Merck & Co., Inc.

Rahway, NJ

$807M
US stock portfolio at live prices · today −$1.6M (−0.20%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$820M
Change from Q2 2026
+$293.9M (+55.84%)
Positions
13 · 0 new, 0 sold out
Filed
Nov 13, 2026

Holdings

Q3 2026 13F, live prices
MRNA 57.0%PSNL 25.6%KYMR 11.4%AKTS 1.94%ALEC 1.01%
StockSharesValue, live% of portfoliovs Q2 2026
MRNA Moderna, Inc.2,308,190$460M57.0%Unchanged
PSNL Personalis, Inc.14,044,943$207M25.6%Unchanged
KYMR Kymera Therapeutics, Inc.772,165$92.2M11.4%Unchanged
AKTS Aktis Oncology, Inc.952,844$15.6M1.94%Unchanged
ALEC Alector, Inc.3,545,719$8.2M1.01%Unchanged
TRDA Entrada Therapeutics, Inc.1,739,768$8.1M1.00%Unchanged
EIKN Eikon Therapeutics, Inc.1,666,666$7.9M0.98%Unchanged
VRDN Viridian Therapeutics, Inc.93,414$2.9M0.36%Unchanged
EVAX Evaxion A/S1,214,126$2.5M0.31%Unchanged
STRO Sutro Biopharma, Inc.272,351$2.4M0.29%Unchanged
XLO Xilio Therapeutics, Inc.105,982$796K<0.1%Unchanged
HURA TuHURA Biosciences, Inc.19,445$26K<0.1%Unchanged
NEUP Neuphoria Therapeutics Inc.10,027$23K<0.1%Unchanged